Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

85-96 of 2022 results
Page 8 of 169
Key Publications December 12, 2022

Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab.

Circulation. 2022;146:657-672

Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators
Acute Coronary Syndromes Cardiovascular Disease Lipids/Lipoproteins
Key Publications December 12, 2022

Exercise timing influences multi-tissue metabolome and skeletal muscle proteome profiles in type 2 diabetic patients - A randomized crossover trial.

Metabolism. 2022;135:155268

Savikj M, Stocks B, Sato S, Caidahl K, Krook A, Deshmukh AS, Zierath JR, Wallberg-Henriksson H
Diabetes Lipids/Lipoproteins Physical Activity/Exercise
Key Publications December 5, 2022

Statin recommendations for primary prevention: more of the same or time for a change?

JAMA. 2022;328:716-718

Navar AM, Peterson ED
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications December 5, 2022

Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force.

JAMA. 2022;328:754-771

Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, Ferencik M
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications December 5, 2022

Reducing disparities in cholesterol control.

JAMA. 2022;328:714-716

Florez H, Hunt KJ, Valencia WM
Cardiovascular Disease Ethnicity Lipids/Lipoproteins
Key Publications December 3, 2022

Trends in lipid concentrations and lipid control among US adults, 2007-2018.

JAMA. 2022;328:737-745

Aggarwal R, Bhatt DL, Rodriguez F, Yeh RW, Wadhera RK
Cardiovascular Disease Ethnicity Lipids/Lipoproteins
Key Publications November 30, 2022

Statin therapy for the primary prevention of cardiovascular disease: Cons.

Atherosclerosis. 2022;356:46-49

Durai V, Redberg RF
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications November 29, 2022

Statin therapy for the primary prevention of cardiovascular disease: Pros.

Atherosclerosis. 2022;356:41-45

Razavi AC, Mehta A, Sperling LS
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications November 25, 2022

Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals.

Metabolism. 2022;134:155247

Tricò D, Mengozzi A, Baldi S, Bizzotto R, Olaniru O, Toczyska K, Huang GC, Seghieri M, Frascerra S, Amiel SA, Persaud S, Jones P, Mari A, Natali A
Insulin Resistance Lipids/Lipoproteins Metabolism: Human Studies
Key Publications November 7, 2022

Compounding benefits of cholesterol-lowering therapy for the reduction of major cardiovascular events: systematic review and meta-analysis.

Circ Cardiovasc Qual Outcomes. 2022;15:e008552

Wang N, Woodward M, Huffman MD, Rodgers A
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications November 4, 2022

Moderate- and high-intensity exercise improves lipoprotein profile and cholesterol efflux capacity in healthy young men.

J Am Heart Assoc. 2022;11:e023386

Stanton KM, Kienzle V, Dinnes DLM, Kotchetkov I, Jessup W, Kritharides L, Celermajer DS, Rye KA
Lipids/Lipoproteins Metabolism: Human Studies Physical Activity/Exercise
Key Publications November 3, 2022

Low-density lipoprotein cholesterol attributable cardiovascular disease risk is sex specific.

J Am Heart Assoc. 2022;11:e024248

Cupido AJ, Asselbergs FW, Schmidt AF, Hovingh GK
Cardiovascular Disease Lipids/Lipoproteins Sex Differences
of 169